miR-27b-3p aggravates steatohepatitis progression by targeting the Nrf2/HO-1 pathway
Animal Bioscience · 01.11.2026 · 39 (11) · 260476
DOI: 10.5713/ab.260476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Bioscience, erschienen am 01.11.2026. Verfasst von Kui Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Yunnan Agricultural University, Kunming, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
The current study aimed to investigate whether miR-27b-3p regulates oxidative stress and inflammatory responses through the Nrf2/HO-1 signaling pathway during the progression of fatty liver. Liver tissues from dairy cows suffering from fatty liver and highfat diet (HFD)-induced fatty liver mice were gathered to assess lipid accumulation, oxidative stress, inflammation, and the expression of miR-27b-3p and components of the Nrf2/HO-1 pathway.
Methods
Liver tissues from dairy cows with fatty liver and HFD-induced fatty liver mice were collected to evaluate lipid accumulation, oxidative stress, inflammation, and the expression of miR-27b-3p and components of the Nrf2/HO-1 pathway. An in vitro steatosis model was established in AML-12 hepatocytes using palmitic acid (PA). Oxidative stress markers (reactive oxygen species [ROS], superoxide dismutase [SOD], and malondialdehyde [MDA]), inflammatory cytokines (IL-1β, IL-6, and TNF-α), and proteins associated with apoptosis were assessed. Bioinformatic analysis and dual-luciferase reporter assays were used to determine the interaction between miR-27b-3p and Nrf2. Functional assays were performed using miR-27b-3p mimetics and antagonists to evaluate its regulatory effects on the Nrf2/HO-1 signaling pathway and downstream cellular responses.
Results
Fatty liver tissues from dairy cows and HFD-fed mice exhibited significant lipid deposition, enhanced oxidative stress, and elevated inflammatory responses, accompanied by upregulation of miR-27b-3p expression and reduced Nrf2/HO-1 signaling activity. Comparable alterations were observed in PA-treated AML-12 cells. Bioinformatic analysis and dual-luciferase experiments validated that miR-27b-3p directly binds to the 3´ untranslated region of Nrf2. Inhibition of miR-27b-3p restored Nrf2 and HO-1 expression, reduced ROS and MDA levels, enhanced SOD activity, suppressed NF-κB activation, decreased pro-inflammatory cytokine production, and alleviated apoptosis. Conversely, the overexpression of miR-27b-3p further inhibited Nrf2/HO-1 signaling and exacerbated oxidative stress, inflammation, and cellular damage.Conclusion: miR-27b-3p accelerates the progression of fatty liver toward steatohepatitis by directly inhibiting Nrf2 and downregulating the Nrf2/HO-1 antioxidant pathway, which increase oxidative stress, inflammatory responses, and hepatocyte apoptosis. These findings identify miR-27b-3p as a key upstream regulator of redox imbalance in fatty liver and suggest that targeting miR-27b-3p could be a promising strategy for the prevention and treatment of bovine fatty liver disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Veterinary Medicine, Yunnan Agricultural University, Kunming, China.
- College of Veterinary Medicine, Yunnan Agricultural University, Kunming, China. xiaobingli@yeah.net.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, K., Pan, H., Tian, Y., Jiang, K., & Li, X. (2026). miR-27b-3p aggravates steatohepatitis progression by targeting the Nrf2/HO-1 pathway. Animal Bioscience, 39(11), 260476. https://doi.org/10.5713/ab.260476
Vancouver
Wang K, Pan H, Tian Y, Jiang K, Li X. miR-27b-3p aggravates steatohepatitis progression by targeting the Nrf2/HO-1 pathway. Animal Bioscience. 2026;39(11):260476. doi:10.5713/ab.260476
BibTeX
@article{Wang2026,
author = {Wang, Kui and Pan, Hao and Tian, Yan and Jiang, Kangfeng and Li, Xiaobing},
title = {miR-27b-3p aggravates steatohepatitis progression by targeting the Nrf2/HO-1 pathway},
journal = {Animal Bioscience},
year = {2026},
volume = {39},
number = {11},
pages = {260476},
doi = {10.5713/ab.260476}
}
EUVIMED